Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

S. Digiambenedetto · SciRah

Researcher profile · Semantic Scholar

S. Digiambenedetto

Share profile

S. Digiambenedetto — researcher profile on SciRah

h-index: 6
Works: 8
Citations: 198

Most-cited papers

Factors influencing the normalization of CD4+ T-cell count, percentage and CD4+/CD8+ T-cell ratio in HIV-infected patients on long-term suppressive antiretroviral therapy.
C. Torti, Mattia Prosperi, D. Motta, S. Digiambenedetto +11 more
2012Clinical Microbiology and Infection74 citations Open access
Semantic Scholar
Systemic inflammation-based scores and mortality for all causes in HIV-infected patients: a MASTER cohort study
E. Raffetti, F. Donato, S. Casari, F. Castelnuovo +8 more
2017BMC Infectious Diseases37 citations Open access
Semantic Scholar
The prognostic role of systemic inflammatory markers on HIV-infected patients with non-Hodgkin lymphoma, a multicenter cohort study
E. Raffetti, F. Donato, F. Castelnuovo, N. Ladisa +11 more
2015Journal of Translational Medicine29 citations Open access
Semantic Scholar
Cohort Profile: Standardized Management of Antiretroviral Therapy Cohort (MASTER Cohort).
C. Torti, E. Raffetti, F. Donato, F. Castelli +37 more
2015International Journal of Epidemiology24 citations
Semantic Scholar
Systemic Inflammation-Based Biomarkers and Survival in HIV-Positive Subject With Solid Cancer in an Italian Multicenter Study
E. Raffetti, F. Donato, Chiara Pezzoli, S. Digiambenedetto +10 more
2015Journal of Acquired Immune Deficiency Syndromes15 citations
Semantic Scholar
Variability of Raltegravir Plasma Levels in the Clinical Setting
S. Fortuna, M. Fabbiani, S. Digiambenedetto, E. Ragazzoni +3 more
2013Pharmacology11 citations
Semantic Scholar
Does simplification to dolutegravir-based dual regimens impact on the CD4+/CD8+ T-cell ratio?
A. Capetti, G. Orofino, L. Paladini, G. Sterrantino +5 more
2018AIDS (London)6 citations Open access
Semantic Scholar
Is Dolutegravir Plus Atazanavir Overburdened With Concentration-Related Neurological Events Compared With Other Dual Regimens?
A. Capetti, C. Atzori, M. Cossu, A. Ciccullo +6 more
2019Open Forum Infectious Diseases2 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

N. Ladisa×5
Invite
N. Ladisa — researcher profile on SciRah
L. Sighinolfi×4
Invite
L. Sighinolfi — researcher profile on SciRah
E. Quiros-Roldan×4
Invite
E. Quiros-Roldan — researcher profile on SciRah
E. Raffetti×4
Invite
E. Raffetti — researcher profile on SciRah

×4

Invite

F. Donato — researcher profile on SciRah

F. Castelnuovo×4

Invite

F. Castelnuovo — researcher profile on SciRah

M. Di Pietro×4

Invite

M. Di Pietro — researcher profile on SciRah

G. Paraninfo×3

Invite

G. Paraninfo — researcher profile on SciRah

Invite

A. Bandera — researcher profile on SciRah

Invite

F. Maggiolo — researcher profile on SciRah

C. Fornabaio×3

Invite

C. Fornabaio — researcher profile on SciRah

Invite

F. Castelli — researcher profile on SciRah